Literature DB >> 8930439

Virology of hepatitis C virus.

P Simmonds1.   

Abstract

Hepatitis C virus (HCV) has been identified as the main causative agent of posttransfusion non-A, non-B hepatitis. Through recently developed diagnostic assays, routine serologic screening of blood donors has prevented most cases of posttransfusion hepatitis. The purpose of this paper is to comprehensively review current information regarding the virology of HCV. Recent findings on the genome organization, its relationship to other viruses, the replication of HCV ribonucleic acid, HCV translation, and HCV polyprotein expression and processing are discussed. Also reviewed are virus assembly and release, the variability of HCV and its classification into genotypes, the geographic distribution of HCV genotypes, and the biologic differences between HCV genotypes. The assays used in HCV genotyping are discussed in terms of reliability and consistency of results, and the molecular epidemiology of HCV infection is reviewed. These approaches to HCV epidemiology will prove valuable in documenting the spread of HCV in different risk groups, evaluating alternative (nonparenteral) routes of transmission, and in understanding more about the origins and evolution of HCV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930439      PMCID: PMC7173289          DOI: 10.1016/s0149-2918(96)80193-7

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  133 in total

1.  HCV genotypes in chronic hepatitis C and response to interferon.

Authors:  K Kanai; M Kako; H Okamoto
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  Hypervariable regions in the putative glycoprotein of hepatitis C virus.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

3.  Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

Authors:  V Bhattacherjee; L E Prescott; I Pike; B Rodgers; H Bell; A R El-Zayadi; M C Kew; J Conradie; C K Lin; H Marsden
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

4.  Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons.

Authors:  Y K Shimizu; H Yoshikura
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 6.  In situ detection of hepatitis C virus--a critical appraisal.

Authors:  J Y Lau; K Krawczynski; F Negro; R P González-Peralta
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

7.  Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

Authors:  E A Brown; H Zhang; L H Ping; S M Lemon
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

8.  Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

Authors:  K Hino; S Sainokami; K Shimoda; S Iino; Y Wang; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

9.  Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.

Authors:  Y K Shimizu; A Iwamoto; M Hijikata; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.

Authors:  Y Higashi; S Kakumu; K Yoshioka; T Wakita; M Mizokami; K Ohba; Y Ito; T Ishikawa; M Takayanagi; Y Nagai
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

View more
  6 in total

1.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

2.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

3.  Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.

Authors:  S S Taremi; B Beyer; M Maher; N Yao; W Prosise; P C Weber; B A Malcolm
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

4.  Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Anita Y M Howe; Johnathan Bloom; Carl J Baldick; Christopher A Benetatos; Huiming Cheng; Joel S Christensen; Srinivas K Chunduru; Glen A Coburn; Boris Feld; Ariamala Gopalsamy; William P Gorczyca; Steve Herrmann; Stephen Johann; Xiaoqun Jiang; Michelle L Kimberland; Girija Krisnamurthy; Matthew Olson; Mark Orlowski; Steve Swanberg; Ian Thompson; Megan Thorn; Alfred Del Vecchio; Dorothy C Young; Marja van Zeijl; John W Ellingboe; Janis Upeslacis; Marc Collett; Tarek S Mansour; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Oncogenic potential of hepatitis C virus proteins.

Authors:  Arup Banerjee; Ratna B Ray; Ranjit Ray
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

6.  Morphogenesis of infectious hepatitis C virus particles.

Authors:  Tetsuro Suzuki
Journal:  Front Microbiol       Date:  2012-02-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.